Axcan, Scandipharm Inc., Trilobite Lakes Corp. deal

AXP increased by $0.50 to $8.50 per share its bid to acquire Scandipharm, a distributor of gastrointestinal, nutritional and cystic fibrosis products (see BioCentury, July 26). AXP’s bid now is $0.50 ...